UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship between tendon structure, stiffness, gait patterns and patient reported outcomes during the early stages of recovery after an Achilles tendon rupture

Scientific reports, 2020-11, Vol.10 (1), p.20757-20757, Article 20757

2020

Volltextzugriff (PDF)

Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects

Science (American Association for the Advancement of Science), 2009-07, Vol.325 (5939), p.490-493

2009

Volltextzugriff (PDF)

The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain

Neuropharmacology, 2009-01, Vol.56 (1), p.254-263

2009

Volltextzugriff (PDF)

Efficacy and Safety of Iptacopan in Patients with C3 Glomerulopathy

Kidney international reports, 2023-12, Vol.8 (12), p.2754-2764

2023

Volltextzugriff (PDF)

Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines

The Journal of pharmacology and experimental therapeutics, 2004-09, Vol.310 (3), p.952

2004

Volltextzugriff (PDF)

Differential roles of mGlu(7) and mGlu(8) in amygdala-dependent behavior and physiology

Neuropharmacology, 2013-09, Vol.72, p.215-223

2013

Volltextzugriff (PDF)

Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect

Psychopharmacologia, 2009-10, Vol.206 (2), p.291-301

2009

Volltextzugriff (PDF)

Differential roles of mGlu7 and mGlu8 in amygdala-dependent behavior and physiology

Neuropharmacology, 2013-09, Vol.72, p.215-223

2013

Volltextzugriff (PDF)

Gastrin-releasing peptide signaling plays a limited and subtle role in amygdala physiology and aversive memory

PloS one, 2012-04, Vol.7 (4), p.e34963-e34963

2012

Volltextzugriff (PDF)

Behavioral effects of cannabinoid agents in animals

Critical reviews in neurobiology, 1999, Vol.13 (3), p.243-281

1999

Volltextzugriff (PDF)

Iptacopan, a Novel Oral Complement Factor B (FB) Inhibitor, Significantly Reduces Proteinuria and C3 Deposit Scores in Native and Transplanted Kidneys C3 Glomerulopathy (C3G) Patients: PO2536

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.B8-B8

2021

Volltextzugriff (PDF)

The selective nicotinic acetylcholine receptor alpha 7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain

Neuropharmacology, 2009-01, Vol.56 (1), p.254-263

2009

Volltextzugriff (PDF)

LBP1 Interim results of an open-label, multicentre, Phase 1/2 study to assess YTB323 (rapcabtagene autoleucel), a CAR T-cell therapy, for severe refractory systemic lupus erythematosus

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A170-A171

2024

Volltextzugriff (PDF)

AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation

British journal of pharmacology, 2015-03, Vol.172 (5), p.1292-1304

2015

Volltextzugriff (PDF)

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

Psychopharmacologia, 1997-07, Vol.132 (1), p.104-106

1997

Volltextzugriff (PDF)

AQW051, a novel, potent and selective [alpha]7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation

British journal of pharmacology, 2015-03, Vol.172 (5), p.1292

2015

Volltextzugriff (PDF)

AQW 051, a novel, potent and selective α 7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation

British journal of pharmacology, 2015-03, Vol.172 (5), p.1292-1304

2015

Volltextzugriff (PDF)

Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity

Naunyn-Schmiedeberg's archives of pharmacology, 2011-12, Vol.384 (6), p.565-581

2011

Volltextzugriff (PDF)

The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain

Neuropharmacology, 2009-01, Vol.56 (1), p.254-263

2009

Volltextzugriff (PDF)

Behavioral Characterization of the Novel GABA B Receptor-Positive Modulator GS39783 ( N , N ′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines

The Journal of pharmacology and experimental therapeutics, 2004-09, Vol.310 (3), p.952-963

2004

Volltextzugriff (PDF)

Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats

Neuropsychopharmacology (New York, N.Y.), 2003-11, Vol.28 (11), p.1903-1915

2003

Volltextzugriff (PDF)

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats

Psychopharmacologia, 1998-02, Vol.135 (4), p.324-332

1998

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Animals
(13)
Male
(11)
Science & Technology
(11)
Mice
(9)
Rats
(9)
Life Sciences & Biomedicine
(8)
Neurosciences
(8)
Mice, Inbred C57bl
(6)
Neurosciences & Neurology
(6)
Pharmacology & Pharmacy
(6)
Rats, Sprague-Dawley
(6)
Biological And Medical Sciences
(5)
Dose-Response Relationship, Drug
(5)
Anxiety
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)
Humans
(4)
Psychology. Psychoanalysis. Psychiatry
(4)
Time Factors
(4)
Medical Sciences
(3)
Mice, Knockout
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relationship between tendon structure, stiffness, gait patterns and patient reported outcomes during the early stages of recovery after an Achilles tendon rupture

Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects

The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain

Efficacy and Safety of Iptacopan in Patients with C3 Glomerulopathy

Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines

Differential roles of mGlu(7) and mGlu(8) in amygdala-dependent behavior and physiology

Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect

Differential roles of mGlu7 and mGlu8 in amygdala-dependent behavior and physiology

Gastrin-releasing peptide signaling plays a limited and subtle role in amygdala physiology and aversive memory

Behavioral effects of cannabinoid agents in animals

Iptacopan, a Novel Oral Complement Factor B (FB) Inhibitor, Significantly Reduces Proteinuria and C3 Deposit Scores in Native and Transplanted Kidneys C3 Glomerulopathy (C3G) Patients: PO2536

The selective nicotinic acetylcholine receptor alpha 7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain

LBP1 Interim results of an open-label, multicentre, Phase 1/2 study to assess YTB323 (rapcabtagene autoleucel), a CAR T-cell therapy, for severe refractory systemic lupus erythematosus

AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

AQW051, a novel, potent and selective [alpha]7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation

AQW 051, a novel, potent and selective α 7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation

Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity

The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain

Behavioral Characterization of the Novel GABA B Receptor-Positive Modulator GS39783 ( N , N ′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines

Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats

Suchergebnisse filtern